Cargando…

Long-term efficacy and adverse effects of cannabidiol in adjuvant treatment of drug-resistant epilepsy: a systematic review and meta-analysis

BACKGROUND: Epilepsy is one of the most common chronic brain diseases. Almost one-third of patients have drug-resistant epilepsy (DRE). Cannabidiol is being considered as a potential novel drug for treating DRE. OBJECTIVES: To investigate long-term efficacy and safety of cannabidiol in treatment of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Shengyi, He, Zihua, Li, Jinmei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2023
Materias:	Systematic Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10617284/ https://www.ncbi.nlm.nih.gov/pubmed/37915501 http://dx.doi.org/10.1177/17562864231207755

Ejemplares similares

Efficacy and Tolerance of Synthetic Cannabidiol for Treatment of Drug Resistant Epilepsy
por: Klotz, Kerstin A., et al.
Publicado: (2019)

Mendelian randomization reveals no causal relationship between COVID‐19 susceptibility, hospitalization, or severity and epilepsy
por: He, Zihua, et al.
Publicado: (2023)

Adverse Events of Cannabidiol Use in Patients With Epilepsy: A Systematic Review and Meta-analysis
por: Fazlollahi, Asra, et al.
Publicado: (2023)

The therapeutic effects of lacosamide on epilepsy-associated comorbidities
por: He, Zihua, et al.
Publicado: (2023)

Is cannabidiol a drug acting on unconventional targets to control drug‐resistant epilepsy?
por: Rocha, Luisa, et al.
Publicado: (2020)

Adverse Effects of Oral Cannabidiol: An Updated Systematic Review of Randomized Controlled Trials (2020–2022)
por: Souza, José Diogo R., et al.
Publicado: (2022)

Cannabidiol in the Treatment of Epilepsy
por: von Wrede, Randi, et al.
Publicado: (2021)

Highly Purified Cannabidiol for Epilepsy Treatment: A Systematic Review of Epileptic Conditions Beyond Dravet Syndrome and Lennox–Gastaut Syndrome
por: Lattanzi, Simona, et al.
Publicado: (2021)

Systematic Review and Meta-Analysis of the Efficacy and Safety of Perampanel in the Treatment of Partial-Onset Epilepsy
por: Hsu, Warrington W. Q., et al.
Publicado: (2013)

Long‐term music adjuvant therapy enhances the efficacy of sub‐dose antiepileptic drugs in temporal lobe epilepsy
por: Xu, Ceng‐Lin, et al.
Publicado: (2021)

Long‐term safety and treatment effects of cannabidiol in children and adults with treatment‐resistant epilepsies: Expanded access program results
por: Szaflarski, Jerzy P., et al.
Publicado: (2018)

Slow Titration of Cannabidiol Add-On in Drug-Resistant Epilepsies Can Improve Safety With Maintained Efficacy in an Open-Label Study
por: D'Onofrio, Gianluca, et al.
Publicado: (2020)

Adjunctive Use of Cannabidiol: A Joint Action to Patch Up Drug-Resistant Epilepsy
por: Karakis, Ioannis
Publicado: (2023)

Use of Cannabidiol in the Treatment of Epilepsy: Efficacy and Security in Clinical Trials
por: Silvestro, Serena, et al.
Publicado: (2019)

Cannabidiol as a treatment for epilepsy
por: Pickrell, William O., et al.
Publicado: (2017)

Cannabidiol in epilepsy: The indications and beyond
por: Ryan, Melody
Publicado: (2020)

Cannabidiol as a Harm Reduction Strategy for People Who Use Drugs: A Rapid Review
por: Lo, Lindsay A., et al.
Publicado: (2023)

Verapamil as an Adjuvant Treatment for Drug-Resistant Epilepsy
por: Lakshmikanthcharan, S., et al.
Publicado: (2018)

Long-term major adverse cardiovascular events following myocardial injury after non-cardiac surgery: meta-analysis
por: Strickland, Scarlett S, et al.
Publicado: (2023)

Cannabidiol Drugs Clinical Trial Outcomes and Adverse Effects
por: Pauli, Christopher S., et al.
Publicado: (2020)

Pharmacogenetic Predictors of Cannabidiol Response and Tolerability in Treatment‐Resistant Epilepsy
por: Davis, Brittney H., et al.
Publicado: (2021)

The efficacy and safety of cannabidiol as adjunct treatment for drug‐resistant idiopathic epilepsy in 51 dogs: A double‐blinded crossover study
por: Rozental, Aaron J., et al.
Publicado: (2023)

Anticonvulsant Action and Long-Term Effects of Chronic Cannabidiol Treatment in the Rat Pentylenetetrazole-Kindling Model of Epilepsy
por: Gáll, Zsolt, et al.
Publicado: (2022)

Cannabidiol Treatment for Refractory Epilepsies in Pediatrics
por: Raucci, Umberto, et al.
Publicado: (2020)

Opportunities, Challenges and Pitfalls of Using Cannabidiol as an Adjuvant Drug in COVID-19 †
por: Malinowska, Barbara, et al.
Publicado: (2021)

Effects of Cannabidiol on Appetite and Body Weight: A Systematic Review
por: Pinto, Joaquim S., et al.
Publicado: (2022)

Cannabidiol and epilepsy in Brazil: a current review
por: Oshiro, Carlos André, et al.
Publicado: (2022)

Systematic Review and Meta-analysis of Interventions to Reduce Adverse Drug Reactions in Older Adults: An Update
por: Gray, Shelly L., et al.
Publicado: (2023)

The adverse effects of long-term exposure to anticholinergics among people with intellectual disabilities: a scoping review
por: Al Shuhaimi, Lamya, et al.
Publicado: (2022)

Malaria infection and the risk of epilepsy: a meta-analysis
por: Alizadeh Khatir, Ali, et al.
Publicado: (2023)

Daily Practice Managing Resistant Multiple Sclerosis Spasticity With Delta-9-Tetrahydrocannabinol: Cannabidiol Oromucosal Spray: A Systematic Review of Observational Studies
por: Akgün, Katja, et al.
Publicado: (2019)

Efficacy and Safety of Opicapone for Motor Fluctuations as an Adjuvant to Levodopa Therapy in Patients with Parkinson’s Disease: A Systematic Review and Meta-Analysis
por: Kwak, Nayoung, et al.
Publicado: (2022)

Potential Adverse Drug Events and Drug–Drug Interactions with Medical and Consumer Cannabidiol (CBD) Use
por: Brown, Joshua D., et al.
Publicado: (2019)

Gastrointestinal Adverse Effects of Short-Term Aspirin Use: A Meta-Analysis of Published Randomized Controlled Trials
por: Baron, John A., et al.
Publicado: (2013)

Cannabidiol for epilepsy (Lennox-Gastaut syndrome, Dravet syndrome)
Publicado: (2020)

An Open Retrospective Study of a Standardized Cannabidiol Based-Oil in Treatment-Resistant Epilepsy
por: Marchese, Francesca, et al.
Publicado: (2022)

Effects of Cannabidiol on Adaptive Behavior and Quality of Life in Pediatric Patients With Treatment-Resistant Epilepsy
por: Kim, Se Hee, et al.
Publicado: (2022)

Therapeutic effect of autologous bone grafting with adjuvant bone morphogenetic protein on long bone nonunion: a systematic review and meta-analysis
por: Xie, Chengxin, et al.
Publicado: (2022)

Efficacy and Safety of the Addition of Internal Mammary Irradiation to Standard Adjuvant Radiation in Early-Stage Breast Cancer: A Systematic Review and Meta-Analysis
por: Korzets, Yasmin, et al.
Publicado: (2022)

Health Consequences of an Elite Sporting Career: Long-Term Detriment or Long-Term Gain? A Meta-Analysis of 165,000 Former Athletes
por: Runacres, Adam, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_r67ctp8j2jr2eh24fo44qgeda4